indazoles has been researched along with Corneal Angiogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acharya, G; Hua, X; Isenhart, LC; Marcano, DC; Pflugfelder, SC; Shin, CS; Yuan, X | 1 |
| Alfonso-Bartolozzi, B; Amparo, F; Chodosh, J; Ciolino, JB; Dana, R; Jin, Y; Jurkunas, U; Sadrai, Z; Schaumberg, DA; Shikari, H; Wang, H | 1 |
1 trial(s) available for indazoles and Corneal Angiogenesis
| Article | Year |
|---|---|
Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization.
Topics: Adult; Aged; Angiogenesis Inhibitors; Corneal Neovascularization; Female; Follow-Up Studies; Humans; Indazoles; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Treatment Outcome; Young Adult | 2013 |
1 other study(ies) available for indazoles and Corneal Angiogenesis
| Article | Year |
|---|---|
Ocular drug delivery nanowafer with enhanced therapeutic efficacy.
Topics: Animals; Axitinib; Cornea; Corneal Neovascularization; Diffusion; Drug Delivery Systems; Drug Liberation; Eye; Female; Imidazoles; Indazoles; Mice; Mice, Inbred C57BL; Nanotechnology; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Wound Healing | 2015 |